- Home
- SABS vs CAPT Comparison
SABS vs CAPT Comparison
Compare SABS & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- CAPT
- Stock Information
- Founded
- SABS 2014
- CAPT 2005
- Country
- SABS United States
- CAPT South Korea
- Employees
- SABS N/A
- CAPT N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- CAPT Blank Checks
- Sector
- SABS Health Care
- CAPT Finance
- Exchange
- SABS Nasdaq
- CAPT Nasdaq
- Market Cap
- SABS 31.2M
- CAPT 25.1M
- IPO Year
- SABS N/A
- CAPT N/A
- Fundamental
- Price
- SABS $4.09
- CAPT $0.78
- Analyst Decision
- SABS Strong Buy
- CAPT
- Analyst Count
- SABS 3
- CAPT 0
- Target Price
- SABS $9.00
- CAPT N/A
- AVG Volume (30 Days)
- SABS 203.1K
- CAPT 5.3M
- Earning Date
- SABS 11-13-2025
- CAPT 01-01-0001
- Dividend Yield
- SABS N/A
- CAPT N/A
- EPS Growth
- SABS N/A
- CAPT N/A
- EPS
- SABS N/A
- CAPT N/A
- Revenue
- SABS $114,698.00
- CAPT $17,389,944.00
- Revenue This Year
- SABS N/A
- CAPT N/A
- Revenue Next Year
- SABS N/A
- CAPT N/A
- P/E Ratio
- SABS N/A
- CAPT N/A
- Revenue Growth
- SABS N/A
- CAPT 84.70
- 52 Week Low
- SABS $1.00
- CAPT $0.37
- 52 Week High
- SABS $6.60
- CAPT $1.94
- Technical
- Relative Strength Index (RSI)
- SABS 71.11
- CAPT 49.60
- Support Level
- SABS $3.68
- CAPT $0.71
- Resistance Level
- SABS $4.15
- CAPT $0.80
- Average True Range (ATR)
- SABS 0.31
- CAPT 0.10
- MACD
- SABS 0.04
- CAPT 0.00
- Stochastic Oscillator
- SABS 93.18
- CAPT 31.95
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.